Neural-immune interactions in health and disease

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2641-2647

  Sternberg, Esther M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CARRAGEENAN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; CYTOKINE RECEPTOR; GLUCOCORTICOID;

ALLERGY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; DEPRESSION; FATIGUE; HEALTH; HELPER CELL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE SYSTEM; INFLAMMATION; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031456504     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119807     Document Type: Review

References (31)

1. Aloisi, F., G. Penna, J. Cerase, I.B. Menendez, and L. Adorini. 1997. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1604-1612.
2. Du, X., E.T. Everett, G. Wang, W.H. Lee, Z. Yang, and D.A. Williams. 1996. Murine interleukin-11 (IL-11 ) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J. Cell. Physiol. 168:362-372.
3. Ericsson, A., C. Liu, R.P. Hart, and P.E. Sawchenko. 1995. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361:681-698.
4. Lee, Y.B., J. Satoh, D.G. Walker, and S.U. Kim. 1996. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport. 7: 1062-1066.
5. Stalder, A.K., A. Pagenstecher, N.C. Yu, C. Kincaid, C.S. Chiang, M.V. Hobbs, F.E. Bloom, and I.L. Campbell. 1997. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 159:1344-1351.
6. Williams, K., N. Dooley, E. Ulvestad, B. Becher, and J.P. Antel. 1996. IL-10 production by adult human derived microglial cells. Neurochem. Intl. 29:55-64.
7. Sei, Y., L. Vitkovic, and M.M. Yokoyama. 1995. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodulation. 2:121-133.
8. Brenneman, D., M. Schultzberg, T. Bartfai, and I. Gozes. 1992. Cytokine regulation of neuronal cell survival. J. Neurochem. 58:454-460.
9. Lipton, S.A. 1997. Janus faces of NF-kB: neurodestruction versus neuroprotection. Nat. Med. 3:20-22.
10. deLuca, A., M. Weller, K. Frei, and A. Fontana. 1996. Maturation-dependent modulation of apoptosis in cultured cerebellar granule neurons by cytokines and neurotrophins. Eur. J. Neurosci. 8:1994-2005.
11. Rothwell, N., S. Allan, and S. Toulmond. 1997. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:2648-2652.
12. Campbell, I.L. 1995. Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci. 13:275-284.
13. Flanders, K.C., C.F. Lippa, T.W. Smith, D.A. Pollen, and M.B. Sporn. 1995. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology. 45:1561-1569.
14. Banks, W.A., and A.J. Kastin. 1997. Relative contributions of peripheral and central sources to levels of IL-1α in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays. J. Neuroimmunol. 79:22-28.
15. Watkins, L.R., S.F. Maier, and L.E. Goehler. 1995. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 57: 1011-1026.
16. Laye, S., R.M. Bluthe, S. Kent, C. Combe, C. Medina, P. Parnet, K. Kelley, and R. Dantzer. 1995. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 268:r1327-r1331.
17. Wong, M.L., V. Rettori, A. al-Shekhlee, P.B. Bongiorno, G. Canteros, S.M. McCann, P.W. Gold, and J. Licinio. 1996. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 2:581-584.
18. DeRijk, R., D. Michelson, B. Karp, J. Petrides, E. Galliven, P. Deuster, G. Paciotti, P.W. Gold, and E.M. Sternberg. 1997. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J. Clin. Endocrinol. Metab. 82:2182-2191.
19. Caldenhoven, E., J. Liden, S. Wissink, A. Van der Stolpe, J. Raaijmakers, L. Koenderman, S. Okret, J.A. Gustafsson, and P.T. Van der Saag. 1995. Negative cross-talk between ReIA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9:401-402.
20. Grota, L.J., T. Bienen, and D.L. Felten. 1997. Corticosterone responses of adult Lewis and Fischer rats. J. Neuroimmunol. 74:95-101.
21. Madden, K.S., J.A. Moynihan, G.J. Brenner, S.Y. Felten, D.L. Felten, and S. Livnat. 1994. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49:77-87.
22. Karalis, K., H. Sano, J. Redwine, S. Listwak, R.L. Wilder, and G.P. Chrousos. 1991. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:421-423.
23. Payan, D.G. 1989, Neuropeptides and inflammation: the role of substance P. Annu. Rev. Med. 40:341-352.
24. Brenneman, D.E., J.M. Hill, G.W. Glazner, I. Gozes, and T.M. Phillips. 1995. Interleukin-1 alpha and vasoactive peptide: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13:187-200.
25. Sternberg, E.M., W.S. Young III, R. Bernardini, A.E. Calogero, G.P. Chrousos, P.W. Gold, and R.L. Wilder. 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA. 86:4771-4775.
26. Misiewicz, B., M. Poltorak, R.B. Raybourne, M. Gomez, S. Listwak, and E.M. Sternberg. 1997. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation. Exp. Neurol. 146:305-314.
27. Goldstein, D.S., M. Garty, G. Bagdy, K. Szeneredi, E.M. Sternberg, S. Listwak, K. Pacak, A. Deka-Starosta, A. Hoffman, P.C. Chang, et al. 1993. Role of CRH in glucopenia-induced adrenomedullary activation in rats. J. Neuroendocrinol. 5:475-486.
28. Zelazowski, P., V.K. Patchev, E.B. Zelazowska, G.P. Chrousos, P.W. Gold, and E.M. Sternberg. 1993. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease. Brain Res. 631:22-26.
29. Schmidt, E.D., A.W. Janszen, F.G. Wouterlood, and F.J. Tilders. 1995. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH): neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J. Neurosci. 15:7417-7426.
30. Remmers, E.F., R.E. Longman, Y. Du, A. O'Hare, G.W. Cannon, M.M. Griffiths, and R.L. Wilder. 1996. A genome scan localizes non-MHC loci controlling collagen-induced arthritis in rats. Nat. Genet. 14:82-85.
31. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.